An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain

Completed

Phase 3 Results

Summary of Purpose

The purpose of this study is to assess the safety of the long-term use of pregabalin at doses up to 600 mg/day in patients with central neuropathic pain (post spinal cord injury pain, post stroke pain, and multiple sclerosis pain).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2013.

1 Sep 2010 31 Aug 2010 1 Mar 2012 1 Mar 2012 1 Apr 2013 10 Jan 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions See All

Sponsors

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available